XOMA Limited (NASDAQ:XOMA)

CAPS Rating: 2 out of 5

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Recs

1
Player Avatar usubanas (99.53) Submitted: 11/20/2012 11:49:34 PM : Outperform Start Price: $3.04 XOMA Score: +6.37

Nov 7 CC: top line data from EYEGUARD-A study at the end of 2013.
I can wait a year.

Member Avatar zzlangerhans (99.74) Submitted: 4/7/2014 5:14:04 PM
Recs: 0

And another year. And another year? Doesn't matter though, waiting isn't a bad strategy on a Baker Bros stock.

Featured Broker Partners


Advertisement